- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02945514
Providing Personally Tailored Dietary Suggestions Using Individual Microbiome and Glycemic Index Response.
February 27, 2018 updated by: Heidi Nelson, Mayo Clinic
Validation of the Measurement and Prediction of the Postprandial Glycemic Response to Food and Providing Personally Tailored Dietary Recommendations
Provide personally tailored dietary suggestions to participants based on the Personalized Prediction Engine (patent pending) owned by DayTwo.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
- Answer personal questions including such things as health information, eating habits and preferences, activity level and intensity.
- Submit a first stool sample via a self-addressed, postage-paid kit that is mailed to you.
- Attend one of the 2 hour connection meetings based on available dates.
- The study team will collect vitals: measurements of height, weight, blood pressure, pulse, waist and hip circumference.
- You will have a Blood collection for study (approximately 35 ml of blood/5 tubes)
- You will be provided a FitBit wrist band that you will wear
- You will be provided a manual blood glucose monitor you will use for pricking finger and measuring blood sugar level at least 4 times per day.
- You will have a continuous blood glucose sensor and monitor inserted by study staff.
- You will use DayTwo's mobile application where you will input food eaten, activity, measurements, medications, and sleep.
- You will be given a second stool kit and instructions for collection.
- You will be asked to eat 4 breakfasts consisting of either bagels and cream cheese or cereal. These foods will be provided for you. Other than these four breakfasts, we would like you to follow your normal eating habits during the collection week.
Study Type
Observational
Enrollment (Actual)
327
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55902-9823
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Men and women above 18 years of age.
Description
Inclusion Criteria:
- 18 years of age or older
- Comprehension of the study objectives and requirements
- Ability to download the DayTwo proprietary mobile application
- Ability to access the DayTwo website for registration and nutrition report
Exclusion Criteria:
- Under 18 years of age
- Pre-diagnosed type I or type II diabetes mellitus
- Pregnancy
- Use of antibiotics or fertility treatments within 3 months prior to participation
- Bariatric weight loss surgery
- Chronic Anemia (hemoglobin of 10g per deciliter or less
- Chronic gastrointestinal disorder (IBD, Celiac, etc.)
- Active cancer or chemotherapy or radiation within 2 years prior to participation
- Condition not allowing to follow the dietary recommendation during the study
- 4 or more alcoholic drinks per day on a regular basis or use of recreational drugs
- Chronic medical condition, treatment, or medication that may affect glucose metabolism (HIV diagnosis, use of steroids or immunosuppressive drugs, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Postprandial blood sugar level
Time Frame: Baseline through 7 days
|
Baseline through 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Heidi Nelson, M.D., Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M, Suez J, Mahdi JA, Matot E, Malka G, Kosower N, Rein M, Zilberman-Schapira G, Dohnalova L, Pevsner-Fischer M, Bikovsky R, Halpern Z, Elinav E, Segal E. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015 Nov 19;163(5):1079-1094. doi: 10.1016/j.cell.2015.11.001.
- Mendes-Soares H, Raveh-Sadka T, Azulay S, Ben-Shlomo Y, Cohen Y, Ofek T, Stevens J, Bachrach D, Kashyap P, Segal L, Nelson H. Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals. Am J Clin Nutr. 2019 Jul 1;110(1):63-75. doi: 10.1093/ajcn/nqz028. Erratum In: Am J Clin Nutr. 2019 Sep 1;110(3):783.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2016
Primary Completion (Actual)
February 27, 2018
Study Completion (Actual)
February 28, 2018
Study Registration Dates
First Submitted
October 24, 2016
First Submitted That Met QC Criteria
October 24, 2016
First Posted (Estimate)
October 26, 2016
Study Record Updates
Last Update Posted (Actual)
February 28, 2018
Last Update Submitted That Met QC Criteria
February 27, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 16-005208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
Clinical Trials on DayTwo machine learning algorithm
-
Duke UniversityUniversity of California, San FranciscoCompletedChemotherapeutic ToxicityUnited States
-
ChronolifeUnknown
-
Norwegian University of Science and TechnologyHelse Nord-Trøndelag HF; SINTEF Health ResearchRecruitingLung Cancer | Artificial Intelligence | Endobronchial UltrasoundNorway
-
Duke UniversityCompletedChemotherapeutic Toxicity | Radiation Therapy ComplicationUnited States
-
London North West Healthcare NHS TrustImperial College LondonActive, not recruiting
-
University of ArkansasCompletedStress Disorders, Post-TraumaticUnited States
-
Abramson Cancer Center at Penn MedicineCompletedColorectal CancerUnited States
-
Royal Marsden NHS Foundation TrustImperial College London; Institute of Cancer Research, United KingdomActive, not recruiting
-
The Christie NHS Foundation TrustManchester University NHS Foundation Trust; Aptus Clinical Ltd.; Zenzium Ltd.Completed